1588-A4 10 mg | ≥98% Cayman Chemical A synthetic intermediate More Information Supplier Page × 1588-A4
LRE1 50 mg | ≥95% Cayman Chemical An allosteric inhibitor of soluble adenylyl cyclase More Information Supplier Page × LRE1
LRE1 5 mg | ≥95% Cayman Chemical An allosteric inhibitor of soluble adenylyl cyclase More Information Supplier Page × LRE1
LRE1 100 mg | ≥95% Cayman Chemical An allosteric inhibitor of soluble adenylyl cyclase More Information Supplier Page × LRE1
LRE1 10 mg | ≥95% Cayman Chemical An allosteric inhibitor of soluble adenylyl cyclase More Information Supplier Page × LRE1
Co 102862 50 mg | ≥95% Cayman Chemical A state-dependent sodium channel inhibitor More Information Supplier Page × Co 102862
Co 102862 5 mg | ≥95% Cayman Chemical A state-dependent sodium channel inhibitor More Information Supplier Page × Co 102862
Co 102862 100 mg | ≥95% Cayman Chemical A state-dependent sodium channel inhibitor More Information Supplier Page × Co 102862
Co 102862 10 mg | ≥95% Cayman Chemical A state-dependent sodium channel inhibitor More Information Supplier Page × Co 102862
L-371,257 5 mg | ≥95% Cayman Chemical A nonpeptide oxytocin receptor antagonist More Information Supplier Page × L-371,257
